Strs Ohio Buys 135,212 Shares of Agilent Technologies, Inc. $A

Key Points

• STRS Ohio increased its Agilent stake by 1,984.3% in Q4, buying 135,212 shares to hold 142,026 shares (about 0.05% of the company) valued at roughly $19.33 million.
• Agilent missed Q4 estimates with $1.36 EPS and $1.80B revenue but raised FY2026 guidance to 5.900–6.040 EPS (Q2 guidance 1.390–1.420), and analysts maintain a consensus "Buy" rating with a mean target of $163.71.

Strs Ohio boosted its holdings in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 1,984.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 142,026 shares of the medical research company's stock after purchasing an additional 135,212 shares during the period. Strs Ohio owned about 0.05% of Agilent Technologies worth $19,325,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Cornerstone Planning Group LLC lifted its stake in Agilent Technologies by 175.3% during the fourth quarter. Cornerstone Planning Group LLC now owns 402 shares of the medical research company's stock worth $54,000 after purchasing an additional 256 shares during the period. Horizon Investments LLC lifted its stake in Agilent Technologies by 7.0% during the fourth quarter. Horizon Investments LLC now owns 8,818 shares of the medical research company's stock worth $1,198,000 after purchasing an additional 576 shares during the period. Oppenheimer & Co. Inc. lifted its stake in Agilent Technologies by 3.1% during the fourth quarter. Oppenheimer & Co. Inc. now owns 9,817 shares of the medical research company's stock worth $1,336,000 after purchasing an additional 294 shares during the period. Jennison Associates LLC lifted its stake in Agilent Technologies by 85.7% during the fourth quarter. Jennison Associates LLC now owns 606,316 shares of the medical research company's stock worth $82,501,000 after purchasing an additional 279,759 shares during the period. Finally, Cardinal Capital Management lifted its stake in Agilent Technologies by 0.4% during the fourth quarter. Cardinal Capital Management now owns 75,091 shares of the medical research company's stock worth $10,218,000 after purchasing an additional 300 shares during the period.

Analysts Set New Price Targets

A number of research analysts have commented on A shares. Barclays cut their price target on shares of Agilent Technologies from $150.00 to $140.00 and set an "overweight" rating for the company in a research note on Tuesday, April 14th. Evercore upgraded shares of Agilent Technologies from an "in-line" rating to an "outperform" rating and raised their price target for the stock from $155.00 to $160.00 in a research note on Monday, January 5th. UBS Group cut their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a "buy" rating for the company in a research note on Thursday, February 26th. Wells Fargo & Company cut their price target on shares of Agilent Technologies from $175.00 to $165.00 and set an "overweight" rating for the company in a research note on Thursday, February 26th. Finally, TD Cowen cut their price target on shares of Agilent Technologies from $170.00 to $157.00 and set a "buy" rating for the company in a research note on Thursday, February 26th. Two research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Buy" and a consensus target price of $163.71.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $114.57 on Monday. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59. The firm has a market cap of $32.38 billion, a P/E ratio of 25.29, a P/E/G ratio of 2.41 and a beta of 1.22. The firm has a 50 day simple moving average of $116.34 and a 200 day simple moving average of $132.45. Agilent Technologies, Inc. has a fifty-two week low of $104.36 and a fifty-two week high of $160.27.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing analysts' consensus estimates of $1.37 by ($0.01). The company had revenue of $1.80 billion during the quarter, compared to analyst estimates of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The business's revenue for the quarter was up 7.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Sell-side analysts predict that Agilent Technologies, Inc. will post 5.95 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st were paid a $0.255 dividend. The ex-dividend date of this dividend was Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a yield of 0.9%. Agilent Technologies's dividend payout ratio (DPR) is presently 22.52%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.